Verbeuren T J, Zonnekeyn L L, Prost J F, Rochat C, Thomas J R, Herman A G
University of Antwerp, Division of Pharmacology, Wilrijk, Belgium.
J Pharmacol Exp Ther. 1988 Aug;246(2):628-34.
The activity of the beta adrenoceptor antagonist tertatolol on renal vasoconstrictions was investigated. Infusion of increasing concentrations of tertatolol (10(-8) to 10(-5) M) progressively inhibited the constrictor responses to bolus injections of norepinephrine and to electrical stimulation in isolated perfused kidneys of both normotensive and spontaneously hypertensive rats. Also, in kidneys of normotensive rats the vasoconstrictions caused by serotonin and barium chloride were inhibited by tertatolol. During sustained vasoconstrictions induced by infusion of norepinephrine (6 X 10(-7) M) increasing doses of tertatolol (2.5 X 10(-7) g to 2 X 10(-5) g) caused rapid, reversible dilatations in the rat kidneys. The inhibitory responses caused by tertatolol were not antagonized by propranolol, atropine, hexamethonium, SCH23390, metoclopramide, mepyramine, cimetidine, naloxone, cocaine or indomethacin. During constrictions caused by norepinephrine, methylene blue significantly inhibited the renal vasodilatations caused by tertatolol, acetylcholine, papaverine and nitroglycerin but not those caused by atrial natriuretic factor. Unlike the other vasodilators, tertatolol did not inhibit the constrictions induced by prostaglandin F2 alpha (5 X 10(-6) M) in the rat kidneys. In canine renal arteries with endothelium, tertatolol (10(-9) to 10(-5) M) did not cause relaxations during contractions induced by norepinephrine, electrical stimulation or prostaglandin F2 alpha. Our data illustrate that tertatolol has potent vasodilator properties in the isolated perfused vasoconstricted rat kidney. The dilator response to the beta blocker cannot be inhibited by a variety of classical receptor blockers but ultimately seems to depend on the formation of cyclic GMP.
研究了β肾上腺素能受体拮抗剂特他洛尔对肾血管收缩的作用。在正常血压和自发性高血压大鼠的离体灌注肾脏中,输注浓度逐渐增加的特他洛尔(10⁻⁸至10⁻⁵M)可逐渐抑制对去甲肾上腺素推注和电刺激的收缩反应。此外,在正常血压大鼠的肾脏中,特他洛尔可抑制血清素和氯化钡引起的血管收缩。在输注去甲肾上腺素(6×10⁻⁷M)诱导的持续性血管收缩期间,增加剂量的特他洛尔(2.5×10⁻⁷g至2×10⁻⁵g)可使大鼠肾脏迅速、可逆地扩张。特他洛尔引起的抑制反应不受普萘洛尔、阿托品、六甲铵、SCH23390、甲氧氯普胺、美吡拉敏、西咪替丁、纳洛酮、可卡因或吲哚美辛的拮抗。在去甲肾上腺素引起的收缩期间,亚甲蓝可显著抑制特他洛尔、乙酰胆碱、罂粟碱和硝酸甘油引起的肾血管舒张,但不抑制心房利钠因子引起的肾血管舒张。与其他血管舒张剂不同,特他洛尔不抑制前列腺素F2α(5×10⁻⁶M)在大鼠肾脏中诱导的收缩。在有内皮的犬肾动脉中,特他洛尔(10⁻⁹至10⁻⁵M)在去甲肾上腺素、电刺激或前列腺素F2α诱导的收缩期间不引起舒张。我们的数据表明,特他洛尔在离体灌注的收缩大鼠肾脏中具有强大的血管舒张特性。对β受体阻滞剂的舒张反应不能被多种经典受体阻滞剂抑制,但最终似乎依赖于环鸟苷酸的形成。